The diamond concept – open questions

doi:10.1016/S0020-1383(08)70010-X

Injury

Volume 39, Supplement 2, September 2008, Pages S5-S8

https://doi.org/10.1016/S0020-1383(08)70010-X Get rights and content

Summary

In the Trauma and Orthopaedic discipline, tissue engineering attempts to convert scientific knowledge into new products and methods of treatment in order to advance the repair, replacement, or regeneration of tissues such as bone, cartilage, tendon and ligament. Currently, tissue engineering strategies are based mainly on cell and tissue-based approaches. We have previously reported that the standard tissue engineering approach to provide solutions for impaired fracture healing, bone restoration and regeneration must include the utilisation of growth factors, scaffolds, mesenchymal stem cells and an optimal mechanical environment (diamond concept). These strategies are already benefiting patients, but as our understanding of the physiological processes increases, a number of questions come up requiring clarification and answers. In this article, important issues which continue to remain obscured are discussed.

References (17)

PV Giannoudis et al.
Fracture healing: a harmony of optimal biology and optimal fixation?
Injury
(2007 Sep)
I Pountos et al.
Pharmacological agents and impairment of fracture healing: what is the evidence?
Injury
(2008 Apr)
PV Giannoudis et al.
Trauma and immune reactivity: too much, or too little immune response?
Injury
(2007 Dec)
PV Giannoudis et al.
Biological enhancement of bone healing with Bone Morphogenetic Protein-7 at the clinical setting of pelvic girdle non-unions
Injury
(2007 Sep)
P Giannoudis et al.
Fracture healing in osteoporotic fractures: is it really different? A basic science perspective
Injury
(2007 Mar)
NK Kanakaris et al.
Biological enhancement of tibial diaphyseal aseptic non-unions: the efficacy of autologous bone grafting, BMPs and reaming by-products
Injury
(2007 May)
G Stylios et al.
Present status and future potential of enhancing bone healing using nanotechnology
Injury
(2007 Mar)
E Tsiridis et al.
Molecular aspects of fracture healing: Which are the important molecules?
Injury
(2007)

There are more references available in the full text version of this article.

Cited by (204)

Development of a 3D multifunctional collagen scaffold impregnated with peptide LL-37 for vascularised bone tissue regeneration
2024, International Journal of Pharmaceutics
Bone is a highly dynamic connective tissue that provides structural support, locomotion and acts as a shield for many vital organs from damage. Bone inherits the ability to heal after non-severe injury. In case of severe bone abnormalities due to trauma, infections, genetic disorders and tumors, there is a demand for a scaffold that can enhance bone formation and regenerate the lost bone tissue. In this study, a 3D collagen scaffold (CS) was functionalized and assessed under in vitro and in vivo conditions. For this, a collagen scaffold coated with hydroxyapatite (Ap-CS) was developed and loaded with a peptide LL-37. The physico-chemical characterisation confirmed the hydroxyapatite coating on the outer and inner surfaces of Ap-CS. In vitro studies confirmed that LL-37 loaded Ap-CS promotes osteogenic differentiation of human osteosarcoma cells without showing significant cytotoxicity. The efficacy of the LL-37 loaded Ap-CS for bone regeneration was evaluated at 4 and 12 weeks post-implantation by histopathological and micro-CT analysis in rabbit femur defect model. The implanted LL-37 loaded Ap-CS facilitated the new bone formation at 4 weeks compared with Ap-CS without LL-37. The LL-37 loaded Ap-CS incorporating apatite and peptide LL-37 would be useful as a multifunctional scaffold for bone tissue engineering.
Physiologically engineered porous titanium/brushite scaffolds for critical-size bone defects: A design and manufacturing study
2023, Journal of the Mechanical Behavior of Biomedical Materials
Repairing critical-size bone defects still represents a critical clinical challenge in the field of trauma surgery. This study focuses on a physiological design and manufacturing of porous composite scaffold (titanium Ti with 10 % mole iron doped brushite DCPD-Fe³⁺) which can mimic the biomechanical properties of natural cortical bone, specifically for the purpose of repairing critical-size defects. To achieve this, the principle of design of experiments (DOE) was applied for investigating the impact of sintering temperature, mineral ratio, and volume fraction of porosity on the mechanical properties of the fabricated scaffolds. The fabricated scaffolds had open porosity up to 60 %, with pore size approximately between 100 μm and 850 μm. The stiffness of the porous composite scaffolds varied between 3.30 GPa and 20.50 GPa, while the compressive strength ranged from approximately 130 MPa–165 MPa at sintering temperatures equal to or exceeding 1000 °C. Scaffolds with higher porosity and mineral content demonstrated lower stiffness values, resembling natural bone. Numerical simulation was employed by Ansys Workbench to investigate the stress and strain distribution of a critical size defect in mid-shaft femur which was designed to be replaced with the fabricated scaffold. The fabricated scaffolds showed flexible biomechanical behaviour at the bone/scaffold interface, generating lower stress levels and indicating a better match with the femoral shaft stiffness. The experimental and numerical findings demonstrated promising applications for manufacturing a patient-specific bone scaffold for critical and potentially large defects for reducing stress shielding and minimizing non-union risk.
The Impact of Injury of the Tibial Nutrient Artery Canal on Type of Nonunion of Tibial Shaft Fractures: A Retrospective Computed Tomography Study
2023, Academic Radiology
Blood supply is vital for sound callus formation. The tibial nutrient artery (TNA) is the main diaphyseal artery nurturing the tibial shaft. The objective is to investigate the impact of TNA canal (TNAC) injury on the development of atrophic, oligotrophic, and hypertrophic nonunion in patients with tibial shaft fractures.
Between January 2010 and December 2020, patients with a nonunion of a tibial shaft fracture were retrospectively included. Two readers independently evaluated the integrity of the TNAC and classified nonunion type. A multinomial regression model was utilized to evaluate if a TNAC injury has an impact on the type of nonunion.
From an initial set of 385 patients with the diagnosis of a nonunion of the lower leg, a total of 60 patients could be finally included in the study. Most patients were males (78%), diabetic (95%), smokers (73%), and had an American Society of Anesthesiologists (ASA) score of 2 (72%). TNAC injury was noted in 24 patients (40%): an iatrogenic TNAC injury was observed in 13 (22%) patients, a traumatic TNAC injury in 11 (18%) patients. Most patients had a hypertrophic nonunion (29 patients (48%)), followed by an oligotrophic nonunion (24 patients (40%)) and lastly an atrophic nonunion (seven patients (11%)). The multinomial regression model showed that there was no impact of TNAC injury on the development of a specific type of non-union (p = 0.798 for oligotrophic vs. atrophic nonunion; p = 0.943 for hypertrophic vs. atrophic nonunion). Furthermore, patients were about four times more likely to develop an oligotrophic/hypertrophic nonunion rather than atrophic one (odds ratio 3.75 and 4.25, respectively), regardless of the presence of a TNAC injury.
In the evaluated patient cohort with tibial shaft fractures, we could not find a statistically significant association between TNAC injury and type of nonunion. However, patients were almost four times more likely to develop oligotrophic or hypertrophic nonunion rather than an atrophic one although common risk factors for impaired (micro)vascular blood supply were highly prevalent in the study group. Multicenter studies with a larger number of atrophic nonunions are warranted to further evaluate this result.
Microfluidic 3D platform to evaluate endothelial progenitor cell recruitment by bioactive materials
2022, Acta Biomaterialia
Most of the conventional in vitro models to test biomaterial-driven vascularization are too simplistic to recapitulate the complex interactions taking place in the actual cell microenvironment, which results in a poor prediction of the in vivo performance of the material. However, during the last decade, cell culture models based on microfluidic technology have allowed attaining unprecedented levels of tissue biomimicry. In this work, we propose a microfluidic-based 3D model to evaluate the effect of bioactive biomaterials capable of releasing signaling cues (such as ions or proteins) in the recruitment of endogenous endothelial progenitor cells, a key step in the vascularization process. The usability of the platform is demonstrated using experimentally-validated finite element models and migration and proliferation studies with rat endothelial progenitor cells (rEPCs) and bone marrow-derived rat mesenchymal stromal cells (BM-rMSCs). As a proof of concept of biomaterial evaluation, the response of rEPCs to an electrospun composite made of polylactic acid with calcium phosphates nanoparticles (PLA+CaP) was compared in a co-culture microenvironment with BM-rMSC to a regular PLA control. Our results show a significantly higher rEPCs migration and the upregulation of several pro-inflammatory and proangiogenic proteins in the case of the PLA+CaP. The effects of osteopontin (OPN) on the rEPCs migratory response were also studied using this platform, suggesting its important role in mediating their recruitment to a calcium-rich microenvironment. This new tool could be applied to screen the capacity of a variety of bioactive scaffolds to induce vascularization and accelerate the preclinical testing of biomaterials.
For many years researchers have used neovascularization models to evaluate bioactive biomaterials both in vitro, with low predictive results due to their poor biomimicry and minimal control over cell cues such as spatiotemporal biomolecule signaling, and in vivo models, presenting drawbacks such as being highly costly, time-consuming, poor human extrapolation, and ethically controversial. We describe a compact microphysiological platform designed for the evaluation of proangiogenesis in biomaterials through the quantification of the level of sprouting in a mimicked endothelium able to react to gradients of biomaterial-released signals in a fibrin-based extracellular matrix. This model is a useful tool to perform preclinical trustworthy studies in tissue regeneration and to better understand the different elements involved in the complex process of vascularization.
Additive manufacturing of biomaterials for bone tissue engineering – A critical review of the state of the art and new concepts
2022, Progress in Materials Science
Citation Excerpt :
How should they be mixed? To the knowledge of the authors, no definitive answer has been described at present [85-88]. Other researchers claim that instead of cells, use of their secretome is enough and safe to regenerate tissue.
Additive manufacturing has attracted keen interest in the medical field in recent decades, especially for bone regeneration. Many additive manufacturing processes have been used to print medical devices such as implants, prostheses, and surgical guides, and for surgical planning in different medical fields, especially orthopedic, maxillofacial and dental surgery. Many materials can be manufactured by 3D printing with metal, ceramic, polymer or composite materials. Composite materials with organic and mineral components have been investigated to mimic bone functional and structural characteristics. In addition to the chemical composition, the modeling and optimization of the design can be optimized to enhance the biological and mechanical performance of the printed scaffolds.
This review presents a comparative evaluation of different material/additive manufacturing processes, and describes the best compromises for targeted clinical applications. The advantages and drawbacks of each additive manufacturing process are described in light of the biological results and essential properties expected by patients and clinicians.
Statement of significance: 3D (bio)printing appears to be an outstanding manufacturing route to revolutionize patient care with personalized medicine. Moreover, there are growing trends in the use of 3D printing in the medical education field and for surgical planning to alleviate surgeon practice and optimize esthetic results. Many reviews have described the growth of the different additive manufacturing techniques developed over time, their advantages and drawbacks and the work required to develop an accurate printable biomaterial fitting the 3D additive manufacturing process and the expectations of the final users and beneficiaries. In this review, an emphasis is placed on the expectations of patients and clinicians regarding specific final clinical applications in craniomaxillofacial, orthopedic or dental fields for a specific biomaterial/additive material (AM) process couple. The primary focus of this review is a comparative analysis of the 4 main additive manufacturing processes used in bone tissue engineering: extrusion-based material, stereolithography, selective laser sintering and inkjet 3D printing. Qualitative and quantitative assessments using a performance index are calculated according to expected criteria for patient care, user-friendly handling, and the affordability of the process. We propose a guideline for users to choose the most appropriate material-process couple.
CD301b<sup>+</sup> macrophages mediate angiogenesis of calcium phosphate bioceramics by CaN/NFATc1/VEGF axis
2022, Bioactive Materials
Calcium phosphate (CaP) bioceramics are important for tissue regeneration and immune response, yet how CaP bioceramics influence these biological processes remains unclear. Recently, the role of immune cells in biomaterial-mediated regeneration, especially macrophages, has been well concerned. CD301b⁺ macrophages were a new subset of macrophages we have discovered, which were required for bioceramics-mediated bone regeneration. Nevertheless, the impact of CD301b⁺ macrophages on angiogenesis, which is a vital prerequisite to bone formation is yet indistinct. Herein, we found that CD301b⁺ macrophages were closely correlated to angiogenesis of CaP bioceramics. Additionally, depletion of CD301b⁺ macrophages led to the failure of angiogenesis. We showed that store-operated Ca²⁺ entry and calcineurin signals regulated the VEGF expression of CD301b⁺ macrophages via the NFATc1/VEGF axis. Inhibition of calcineurin effectively impaired angiogenesis via decreasing the infiltration of CD301b⁺ macrophages. These findings provided a potential immunomodulatory strategy to optimize the integration of angiogenesis and bone tissue engineering scaffold materials.

View all citing articles on Scopus

View full text